IRIS

Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab / Mazzaschi, G; Facchinetti, F; Madeddu, D; Buti, S; Gelsomino, F; Ardizzoni, A; Aversa, F; Missale, G; Quaini, F; Tiseo, M. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 13:supplement 4(2018). [10.1016/S1556-0864(18)30281-8]

Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab

Mazzaschi G;Buti S;Missale G;Quaini F;Tiseo M
2018-01-01
2018
Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab / Mazzaschi, G; Facchinetti, F; Madeddu, D; Buti, S; Gelsomino, F; Ardizzoni, A; Aversa, F; Missale, G; Quaini, F; Tiseo, M. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 13:supplement 4(2018). [10.1016/S1556-0864(18)30281-8]
1.5 Abstract in Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906899
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact